Maria Kislova

8PUBLICATIONS
66CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Central and Eastern European languages (incl. Russian)Respiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 19, 2026
Minimal residual disease-guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype.

|Aug 10, 2026
Allogeneic Stem Cell Transplantation-A Salvage Option for High-Risk Chronic Lymphocytic Leukemia Patients: A 15-Year Single-Center Experience.

|Feb 20, 2026
[Characteristics and 5-year outcomes in patients with chronic lymphocytic leukemia receiving ibrutinib (a real-world study)].

U P Ergasheva, E P Panchenko, C G Chernyshenko

|Oct 24, 2025
Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL.

Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel

|May 18, 2023
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.

Eugene Nikitin, Maria Kislova, Dmitry Morozov

|Apr 14, 2023
Significant reduction in the incidence of non-coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID-19 pandemic: An additional benefit of lockdown.

Maria Kislova, Andrei Petrenko, Elena A Dmitrieva

Pageof 2

Frequent Collaborators

6 joint publications

Elena Dmitrieva

5 joint publications

Vadim V Ptushkin

5 joint publications

Eugene Nikitin

2 joint publications

Andrey Sudarikov